Press Releases

Curbing Atherosclerosis and Precision Medicine are the Main Strategies to Transform the Landscape of Treatments to Prevent Heart Attacks and Strokes

October 26, 2015

Cardiovascular diseases are responsible for the largest number of deaths in the world. “Curbing atherosclerosis will require a multi-faceted approach targeting LDL-cholesterol, high-density lipoproteins (HDL) and probably inflammation”, explained Dr.

Read more
The MHI, the association des cardiologues du Québec and the IUCPQ have tabled a brief at the National Assembly regarding Bill 44

August 18, 2015

The MHI, the association des cardiologues du Québec and the IUCPQ have tabled a brief that includes measures to prevent diseases related to tobacco consumption and, more specifically, ways to regulate the sale and use of electronic cigarettes.
Read more
Dalcor Pharma licenses a late-stage investigational drug following a major discovery by the MHI

June 8, 2015

DALCOR PHARMA LICENSES A LATE-STAGE INVESTIGATIONAL CARDIOVASCULAR DRUG FOLLOWING MAJOR DISCOVERY BY MONTREAL HEART INSTITUTE (MHI) SCIENTISTS
New company DalCor to sponsor global phase III clinical trial to be led by MHI

Read more
MHI and AstraZeneca to screen samples for cardiovascular and diabetes genetic traits

May 13, 2015

The Montreal Heart Institute (MHI) today announced a collaboration with AstraZeneca, to search the genomes of up to 80,000 patients for genes associated with cardiovascular diseases and diabetes, their complications and treatment outcomes.
Read more
The Institute Biobank Celebrates its 20,000th Participant

February 4, 2015

Audrey Sirois, a 26-year-old patient, has become the 20,000th participant in the Montreal Heart Institute Biobank. Eventually, the Biobank will help the Institute's specialists and researchers better understand the genetic bases and other risk factors of cardiovascular disease.
Read more
The Effect of Statins Influenced by Gene Profiles

2014, October 28, 2014

The Montreal Heart Institute Research Centre is once again pushing the limits of knowledge in personalized medicine. A meta-analysis combining the results of several pharmacogenomic studies and involving over 40,000 research subjects now makes it possible to demonstrate a different response to statins according to the patient's gene profile.
Read more
Fish oil supplements have little effect on irregular heartbeat

2014, October 14, 2014

High doses of fish oil supplements, rich in omega-3 fatty acids, do not reduce atrial fibrillation, a common type of irregular heartbeat in which the heart can beat as fast as 150 beats a minute. The results of the AFFORD trial led by the Montreal Heart Institute were published in the Journal of the American College of Cardiology on October 7th.
Read more
The Montreal Heart Institute Honours its Builders

2014, March 25, 2014

On March 25, as part of its 60th anniversary celebrations, the Montreal Heart Institute (MHI) honoured three of its builders: internationally renowned cardiologists Dr. Paul David, founder of the MHI, and Dr. Martial Bourassa, first director of the Research Centre, as well as Mr. J.-Louis Lévesque, philanthropist. The event was held at Maison Birks, a partner of the MHI's 60th anniversary celebrations.
Read more
Dr Stanley Nattel receives honorary doctorate from the University of Szeged in Hungary

2013, November 26, 2013

Dr. Stanley Nattel, clinical cardiologist and Director of the Electrophysiology Research Program at the Research Centre of the Montreal Heart Institute (MHI), has received a prestigious Doctorem Honoris Causa from the University of Szeged in Hungary, one of the prominent medical schools of Europe.
Read more
Heart valve repair or replacement: new findings will have a major impact on surgical practice

2013, November 18, 2013

A study published today in The New England Journal of Medicine and presented at the American Heart Association's Scientific Sessions 2013 marks a decisive step in the practice of heart surgery. A group of North American researchers compared two types of heart surgery to treat mitral valve failure, a very common heart defect that is estimated to affect approximately one out of five people over the age of 55. The study results seem to indicate that mitral valve replacement provides longer lasting protection than mitral valve repair.
Read more

Demandes des chercheurs - FUCRC

Press Releases

Curbing Atherosclerosis and Precision Medicine are the Main Strategies to Transform the Landscape of Treatments to Prevent Heart Attacks and Strokes

The MHI, the association des cardiologues du Québec and the IUCPQ have tabled a brief at the National Assembly regarding Bill 44

Dalcor Pharma licenses a late-stage investigational drug following a major discovery by the MHI

MHI and AstraZeneca to screen samples for cardiovascular and diabetes genetic traits

The Institute Biobank Celebrates its 20,000th Participant

The Effect of Statins Influenced by Gene Profiles

Fish oil supplements have little effect on irregular heartbeat

The Montreal Heart Institute Honours its Builders

Dr Stanley Nattel receives honorary doctorate from the University of Szeged in Hungary

Heart valve repair or replacement: new findings will have a major impact on surgical practice

Pages

Search form

Demandes des chercheurs - FUCRC

Press Releases

Pages